Targeted clinical research to address select viral infections

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201600018C
Awardee
Awarding agency
Obligated
$9,327,650

Award facts

Opportunity
Contract value 100% obligated
$9,327,649.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Birmingham, AL 35294, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 -$4,230,217
Other Administrative Action P00015 $0
Funding Only Action P00014 -$41,870
Funding Only Action P00013 -$7,085
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 · To conduct clinical investigation of serious and life-threatening viral infections in pediatric populations (including neonates). $0
Other Administrative Action P00009 · Clinical protocol and study design development $0
Funding Only Action P00008 · Option 1. 07/01/2019 - 06/30/2024. Targeted clinical research to address select viral infections. $10,184,766
Change Order P00007 · Base. 02/11/2019 - 03/20/2022. Targeted clinical research to address select viral infections. $893,003
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Exercise an Option 3 $701,660
Change Order 2 · Base. 07/24/2017 - 06/30/2020. Targeted clinical research to address select viral infections. $997,527
Change Order 1 $0
Other Administrative Action 4 · Base. 07/24/2017 - 06/30/2020. Targeted clinical research to address select viral infections. $0
Original award $829,866
Show all 17

About this award

Written by GovTribe AI ·

This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB). The $9,327,649.94 contract is for "Targeted Clinical Research to Address Select Viral Infections" and does not have a set-aside designation.

The contract includes clinical research at multiple sites, including UAB and its subcontractors, to address viral infections. Subcontractors include academic medical centers, universities, and research institutes located across the U.S. and internationally, such as the Medical University of South Carolina, University of Southern California, and University of Rochester. This contract supports NIAID's mission to conduct and support research to understand, treat, and prevent infectious diseases.

Subawards

Subcontractor Amount Awarded
The Medical University Of South Carolina TO CONDUCT CLINICAL INVESTIGATION OF SERIOUS AND LIFE-THREATENING VIRAL INFECTIONS IN PEDIATRIC POPULATIONS (INCLUDING NEONATES). Participate in clinical… $25,750
Oxford University Hospitals NHS Foundation Trust TO CONDUCT CLINICAL INVESTIGATION OF SERIOUS AND LIFE-THREATENING VIRAL INFECTIONS IN PEDIATRIC POPULATIONS (INCLUDING NEONATES). Protocol and site setup by… $31,500

Quick answers

Who was awarded contract HHSN272201600018C?

HHSN272201600018C was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 30, 2016.

How much is contract HHSN272201600018C worth?

The government has obligated $9,327,650 on HHSN272201600018C.

Was contract HHSN272201600018C competed?

The extent of competition for HHSN272201600018C was full and open competition. The government received 13 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login